| 000 | 01860 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515112757.0 | ||
| 264 | 0 | _c20080626 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a0049-8254 | ||
| 024 | 7 |
_a10.1080/00498250701827685 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPan, Y | |
| 245 | 0 | 0 |
_aPharmacokinetic characterization of hydroxylpropyl-beta-cyclodextrin-included complex of cryptotanshinone, an investigational cardiovascular drug purified from Danshen (Salvia miltiorrhiza). _h[electronic resource] |
| 260 |
_bXenobiotica; the fate of foreign compounds in biological systems _cApr 2008 |
||
| 300 |
_a382-98 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a2-Hydroxypropyl-beta-cyclodextrin |
| 650 | 0 | 4 | _aAbietanes |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiovascular Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aDrugs, Chinese Herbal _xadministration & dosage |
| 650 | 0 | 4 |
_aDrugs, Investigational _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhenanthrenes _xadministration & dosage |
| 650 | 0 | 4 |
_aPhenanthrolines _xchemistry |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSalvia miltiorrhiza _xchemistry |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 |
_abeta-Cyclodextrins _xadministration & dosage |
| 700 | 1 | _aBi, H-C | |
| 700 | 1 | _aZhong, G-P | |
| 700 | 1 | _aChen, X | |
| 700 | 1 | _aZuo, Z | |
| 700 | 1 | _aZhao, L-Z | |
| 700 | 1 | _aGu, L-Q | |
| 700 | 1 | _aLiu, P-Q | |
| 700 | 1 | _aHuang, Z-Y | |
| 700 | 1 | _aZhou, S-F | |
| 700 | 1 | _aHuang, M | |
| 773 | 0 |
_tXenobiotica; the fate of foreign compounds in biological systems _gvol. 38 _gno. 4 _gp. 382-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00498250701827685 _zAvailable from publisher's website |
| 999 |
_c17842235 _d17842235 |
||